Dallas County prepares to change distribution of monkeypox vaccine


Dallas County is preparing to administer the vaccine “intradermally,” meaning between the layers of the skin, rather than under the skin.

DALLAS — Dallas County Health and Human Services is preparing to administer the Jynneos monkeypox vaccine “intradermally,” which means between the layers of the skin, rather than under the skin.

The FDA on Tuesday issued an emergency use authorization for the intradermal injection. The procedure significantly expands the vaccine supply, DCHHS Director Dr. Philip Huang told WFAA.

“This increases the number of people we can administer the vaccine to by five times,” Dr Huang said.

Currently, Dallas County has approximately 1,500 vaccine vials. Multiplied by five, intradermally, these vials can vaccinate 7,500 North Texans.

Dr Huang said his team could not administer the vaccine intradermally immediately.

“Hopefully in the next few days, I don’t know exactly,” he told the WFAA.

This is because the new procedure requires new syringes and needles, Dr Huang said.

“We kind of have to retrain staff with the new procedure. But we’re going through that process right now,” he said.

And when they’re done, Dr. Huang predicts his team will be able to expand vaccine eligibility even further.

Currently, these are the only two groups eligible for DCHHS:

  • People who have had close, intimate, skin-to-skin contact with someone who tested positive for monkeypox.
  • Men (cisgender and transgender) 18 years and older who have sex with men and who also had multiple or anonymous sex partners in the past 14 days.


Comments are closed.